Innovative Cellular Therapeutics Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Subsidiary
- Established
- 2009-08-27
- Employees
- 51
- Market Cap
- -
- Website
- http://www.sidansai.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)CART Therapy in Digestive System Tumors
Not Applicable
Not yet recruiting
- Conditions
- Malignant Neoplasms of Digestive Organs
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Innovative Cellular Therapeutics Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT04780529
- Locations
- 🇨🇳
Anhui provincial cancer hospital, Hefei, Anhui, China
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Not Applicable
- Conditions
- Leukemia, B-CellLymphoma, B-Cell
- First Posted Date
- 2016-06-27
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Innovative Cellular Therapeutics Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02813837
- Locations
- 🇨🇳
Innovative Cellular Therapeutics CO., LTD., Shanghai, China
News
No news found